Log In
BCIQ
Print this Print this
 

IMD-0354

  Manage Alerts
Collapse Summary General Information
Company IMMD Inc.
DescriptionTopical inhibitor of kappa light polypeptide gene enhancer in B cells kinase beta (IKBKB; IKK2)
Molecular Target Inhibitor of kappa light polypeptide gene enhancer in B cells kinase beta (IKKbeta) (IKBKB) (IKK2) (NRKBIKB)
Mechanism of ActionI-kappa B kinase (IKK) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today